Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.
Dunkel Y, Diao K, Aznar N, Swanson L, Liu L, Zhu W, Mi XY, Ghosh P.
Dunkel Y, et al. Among authors: aznar n.
FASEB J. 2016 Nov;30(11):3702-3713. doi: 10.1096/fj.201600500. Epub 2016 Jul 20.
FASEB J. 2016.
PMID: 27440794
Free PMC article.
Further studies on larger cohorts are essential to rigorously assess the effectiveness and robustness of this algorithm in prognosticating outcome among patients with breast cancer.-Dunkel, Y., Diao, K., Aznar, N., Swanson, L., Liu, L., Zhu, W., Mi, X.-Y., Ghosh, P. …
Further studies on larger cohorts are essential to rigorously assess the effectiveness and robustness of this algorithm in prognosticating o …